Xyosted - A Testosterone Auto-Injector for Hypogonadism

Date: March 11, 2019
Issue #: 
1567Summary: 
The FDA has approved an auto-injector formulation of
testosterone enanthate (Xyosted– Antares Pharma) for
once-weekly subcutaneous self-administration in adult
males with conditions associated with a deficiency or
absence of endogenous testosterone. It is the first subcutaneous
formulation of testosterone to be approved by
the FDA.Xyosted is contraindicated for treatment of low
testosterone levels associated with aging.

Source: The Medical Letter - February 20, 2019 Category: Drugs & Pharmacology Authors: admin Tags: Aveed Depo-Testosterone Hypogonadism Xyosted Source Type: research